分枝杆菌硫代谢中的药物靶点。
Drug targets in mycobacterial sulfur metabolism.
作者信息
Bhave Devayani P, Muse Wilson B, Carroll Kate S
机构信息
Chemical Biology Ph.D. Program, University of Michigan, Ann Arbor, Michigan, 48109-2216, USA.
出版信息
Infect Disord Drug Targets. 2007 Jun;7(2):140-58. doi: 10.2174/187152607781001772.
Abstract
The identification of new antibacterial targets is urgently needed to address multidrug resistant and latent tuberculosis infection. Sulfur metabolic pathways are essential for survival and the expression of virulence in many pathogenic bacteria, including Mycobacterium tuberculosis. In addition, microbial sulfur metabolic pathways are largely absent in humans and therefore, represent unique targets for therapeutic intervention. In this review, we summarize our current understanding of the enzymes associated with the production of sulfated and reduced sulfur-containing metabolites in Mycobacteria. Small molecule inhibitors of these catalysts represent valuable chemical tools that can be used to investigate the role of sulfur metabolism throughout the Mycobacterial lifecycle and may also represent new leads for drug development. In this light, we also summarize recent progress in the development of inhibitors of sulfur metabolism enzymes.
摘要
迫切需要鉴定新的抗菌靶点，以应对多重耐药和潜伏性结核感染。硫代谢途径对于包括结核分枝杆菌在内的许多病原菌的生存和毒力表达至关重要。此外，人类基本不存在微生物硫代谢途径，因此，它是治疗干预的独特靶点。在这篇综述中，我们总结了目前对分枝杆菌中与硫酸化和还原态含硫代谢物产生相关的酶的理解。这些催化剂的小分子抑制剂是有价值的化学工具，可用于研究硫代谢在分枝杆菌整个生命周期中的作用，也可能代表药物开发的新线索。鉴于此，我们还总结了硫代谢酶抑制剂开发的最新进展。
相似文献
1
Drug targets in mycobacterial sulfur metabolism.
Infect Disord Drug Targets. 2007 Jun;7(2):140-58. doi: 10.2174/187152607781001772.
2
New targets and inhibitors of mycobacterial sulfur metabolism.
Infect Disord Drug Targets. 2013 Apr;13(2):85-115. doi: 10.2174/18715265113139990022.
3
Mycobacterium sulfur metabolism and implications for novel drug targets.
Cell Biochem Biophys. 2013 Mar;65(2):77-83. doi: 10.1007/s12013-012-9410-x.
4
Mycothiol: a target for potentiation of rifampin and other antibiotics against Mycobacterium tuberculosis.
Expert Rev Anti Infect Ther. 2013 Jan;11(1):49-67. doi: 10.1586/eri.12.152.
5
Editorial: Current status and perspective on drug targets in tubercle bacilli and drug design of antituberculous agents based on structure-activity relationship.
Curr Pharm Des. 2014;20(27):4305-6. doi: 10.2174/1381612819666131118203915.
6
Functional demonstration of reverse transsulfuration in the Mycobacterium tuberculosis complex reveals that methionine is the preferred sulfur source for pathogenic Mycobacteria.
J Biol Chem. 2005 Mar 4;280(9):8069-78. doi: 10.1074/jbc.M412540200. Epub 2004 Dec 2.
7
Discovery of sulfated metabolites in mycobacteria with a genetic and mass spectrometric approach.
Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17037-42. doi: 10.1073/pnas.252514899. Epub 2002 Dec 13.
8
Uncovering the roles of in redox and bioenergetic homeostasis: implications for antitubercular therapy.
mSphere. 2024 Apr 23;9(4):e0006124. doi: 10.1128/msphere.00061-24. Epub 2024 Apr 2.
9
Small organic molecules targeting the energy metabolism of Mycobacterium tuberculosis.
Eur J Med Chem. 2021 Feb 15;212:113139. doi: 10.1016/j.ejmech.2020.113139. Epub 2020 Dec 29.
10
Divergent downstream biosynthetic pathways are supported by <sc>L</sc>-cysteine synthases of .
Elife. 2024 Aug 29;12:RP91970. doi: 10.7554/eLife.91970.
引用本文的文献
1
The Effect of Sulphur Atom on the Structure of Biomolecule 2-Thiocytosine in the Gas-Phase, Solid-State, and Hydrated Forms and in DNA-DNA Microhelices as Compared to Canonical Ones.
Molecules. 2025 Jan 26;30(3):559. doi: 10.3390/molecules30030559.
2
The structural and functional analysis of mycobacteria cysteine desulfurase-loaded encapsulin.
Commun Biol. 2024 Dec 19;7(1):1656. doi: 10.1038/s42003-024-07299-8.
3
Comparative Proteomic Analysis of Cell Wall Proteins of Aminoglycosides Resistant and Sensitive Clinical Isolates.
Curr Protein Pept Sci. 2025;26(5):392-405. doi: 10.2174/0113892037334796240927055243.
4
Role of Carbon, Nitrogen, Phosphate and Sulfur Metabolism in Secondary Metabolism Precursor Supply in spp.
Microorganisms. 2024 Jul 31;12(8):1571. doi: 10.3390/microorganisms12081571.
5
Prominent transcriptomic changes in Mycobacterium intracellulare under acidic and oxidative stress.
BMC Genomics. 2024 Apr 17;25(1):376. doi: 10.1186/s12864-024-10292-4.
6
Mycobacteriaceae Phenome Atlas (MPA): A Standardized Atlas for the Mycobacteriaceae Phenome Based on Heterogeneous Sources.
Phenomics. 2023 Jun 13;3(5):439-456. doi: 10.1007/s43657-023-00101-5. eCollection 2023 Oct.
7
Adenylyl-Sulfate Kinase (Met14)-Dependent Cysteine and Methionine Biosynthesis Pathways Contribute Distinctively to Pathobiological Processes in Cryptococcus neoformans.
Microbiol Spectr. 2023 Jun 15;11(3):e0068523. doi: 10.1128/spectrum.00685-23. Epub 2023 Apr 10.
8
Cyanide replaces substrate in obligate-ordered addition of nitric oxide to the non-heme mononuclear iron AvMDO active site.
J Biol Inorg Chem. 2023 Apr;28(3):285-299. doi: 10.1007/s00775-023-01990-7. Epub 2023 Feb 21.
9
Combatting antimicrobial resistance via the cysteine biosynthesis pathway in bacterial pathogens.
Biosci Rep. 2022 Oct 28;42(10). doi: 10.1042/BSR20220368.
10
Bacterial virulence factors: a target for heterocyclic compounds to combat bacterial resistance.
RSC Adv. 2021 Nov 19;11(58):36459-36482. doi: 10.1039/d1ra06238g. eCollection 2021 Nov 10.
本文引用的文献
1
Sulfotransferases as targets for therapeutic intervention.
Curr Opin Drug Discov Devel. 2000 Sep;3(5):502-15.
2
Vaccine efficacy of an attenuated but persistent Mycobacterium tuberculosis cysH mutant.
J Med Microbiol. 2007 Apr;56(Pt 4):454-458. doi: 10.1099/jmm.0.46983-0.
3
3'-Phosphoadenosine-5'-phosphosulfate reductase in complex with thioredoxin: a structural snapshot in the catalytic cycle.
Biochemistry. 2007 Apr 3;46(13):3942-51. doi: 10.1021/bi700130e. Epub 2007 Mar 13.
4
Inhibitors of bacterial cystathionine beta-lyase: leads for new antimicrobial agents and probes of enzyme structure and function.
J Med Chem. 2007 Feb 22;50(4):755-64. doi: 10.1021/jm061132r.
5
Mycothiol-dependent proteins in actinomycetes.
FEMS Microbiol Rev. 2007 Apr;31(3):278-92. doi: 10.1111/j.1574-6976.2006.00062.x. Epub 2007 Feb 26.
6
Two polyketide-synthase-associated acyltransferases are required for sulfolipid biosynthesis in Mycobacterium tuberculosis.
Microbiology (Reading). 2007 Feb;153(Pt 2):513-520. doi: 10.1099/mic.0.2006/003103-0.
7
Recombineering in Mycobacterium tuberculosis.
Nat Methods. 2007 Feb;4(2):147-52. doi: 10.1038/nmeth996. Epub 2006 Dec 17.
8
Who puts the tubercle in tuberculosis?
Nat Rev Microbiol. 2007 Jan;5(1):39-47. doi: 10.1038/nrmicro1538. Epub 2006 Dec 11.
9
Design and synthesis of substrate-mimic inhibitors of mycothiol-S-conjugate amidase from Mycobacterium tuberculosis.
Bioorg Med Chem Lett. 2007 Jan 15;17(2):444-7. doi: 10.1016/j.bmcl.2006.10.031. Epub 2006 Oct 17.
10
Noncovalent complexes of APS reductase from M. tuberculosis: delineating a mechanistic model using ESI-FTICR MS.
J Am Soc Mass Spectrom. 2007 Feb;18(2):167-78. doi: 10.1016/j.jasms.2006.08.010. Epub 2006 Oct 4.
Zotero 插件